Molecure Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Molecure stock has a consensus rating of "Strong Buy" and an average price target of zł 12.45. The average 1-year stock price forecast is 101.78% higher than the current stock price, while the lowest is zł 9.90 (+60.45%) and the highest is zł 15.00 (+143.11%).

Price Target: zł 12.45 (+101.78%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	zł 9.90	zł 12.45	zł 12.45	zł 15.00
Change	+60.45%	+101.78%	+101.78%	+143.11%

Analyst Ratings

The average analyst rating for Molecure stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Oct '25	Jan '26	Mar '26	Apr '26	May '26	Jul '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

2.00M

from 6.52M

-69.32%

from 6.52M

Revenue Next Year

3.00M

from 2.00M

50.00%

from 2.00M

EPS This Year

-1.80

from -

EPS Next Year

-1.70

from -1.80

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.17M	7.51M	3.65M	2.92M	6.52M	2.00M
Revenue Growth	-99.07%	543.32%	-51.39%	-20.08%	123.34%	-69.32%
Operating Income	-13.76M	-37.67M	-32.13M	-32.30M	-16.56M	-14.00M
Net Income	-13.64M	-35.95M	-28.37M	-31.29M	-15.69M	-13.00M
EPS	-	-	-	-	-	-1.80
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.

Revenue Forecast

Chart

Revenue	2026	2027
High	2.0M
Avg	2.0M
Low	2.0M

Revenue Growth

Chart

Revenue Growth	2026	2027
High	-69.3%
Avg	-69.3%
Low	-69.3%

EPS Forecast

Chart

EPS	2026	2027
High	-1.80
Avg	-1.80
Low	-1.80

EPS Growth

Chart

EPS Growth	2026	2027
High	-
Avg	-
Low	-